Please use this identifier to cite or link to this item:
https://hdl.handle.net/11000/30557
Full metadata record
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Saposnik, Gustavo | - |
dc.contributor.author | Maurino, Jorge | - |
dc.contributor.author | Perez-Sempere, Angel | - |
dc.contributor.author | Ruff, Christian | - |
dc.contributor.author | Tobler, Philippe | - |
dc.contributor.other | Departamentos de la UMH::Medicina Clínica | es_ES |
dc.date.accessioned | 2024-01-22T17:52:24Z | - |
dc.date.available | 2024-01-22T17:52:24Z | - |
dc.date.created | 2017-01 | - |
dc.identifier.citation | Patient Preference and Adherence Volume 11, 2017 | es_ES |
dc.identifier.issn | 1177-889X | - |
dc.identifier.uri | https://hdl.handle.net/11000/30557 | - |
dc.description.abstract | Abstract Purpose Herding is a phenomenon by which individuals follow the behavior of others rather than deciding independently on the basis of their own private information. A herding-like phenomenon can occur in multiple sclerosis (MS) when a neurologist follows a therapeutic recommendation by a colleague even though it is not supported by best practice clinical guidelines. Limited information is currently available on the role of herding in medical care. The objective of this study was to determine the prevalence (and its associated factors) of herding in the management of MS. Methods We conducted a study among neurologists with expertise in MS care throughout Spain. Participants answered questions regarding the management of 20 case scenarios commonly encountered in clinical practice and completed 3 surveys and 4 experimental paradigms based on behavioral economics. The herding experiment consisted of a case scenario of a 40-year-old woman who has been stable for 3 years on subcutaneous interferon and developed a self-limited neurological event. There were no new magnetic resonance imaging (MRI) lesions. Her neurological examination and disability scores were unchanged. She was advised by an MS neurologist to switch from interferon to fingolimod against best practice guidelines. Multivariable logistic regression analysis was conducted to evaluate factors associated with herding. Results Out of 161 neurologists who were invited to participate, 96 completed the study (response rate: 60%). Herding was present in 75 (78.1%), having a similar prevalence in MS experts and general neurologists (68.8% vs 82.8%; P=0.12). In multivariate analyses, the number of MS patients seen per week was positively associated with herding (odds ratio [OR] 1.08, 95% CI 1.01–1.14). Conversely, physician’s age, gender, years of practice, setting of practice, or risk preferences were not associated with herding. Conclusion Herding was a common phenomenon affecting nearly 8 out of 10 neurologists caring for MS patients. Herding may affect medical decisions and lead to poorer outcomes in the management of MS. | es_ES |
dc.format | application/pdf | es_ES |
dc.format.extent | 6 | es_ES |
dc.language.iso | eng | es_ES |
dc.publisher | Taylor and Francis Group | es_ES |
dc.rights | info:eu-repo/semantics/openAccess | es_ES |
dc.rights | Attribution-NonCommercial-NoDerivatives 4.0 Internacional | * |
dc.rights.uri | http://creativecommons.org/licenses/by-nc-nd/4.0/ | * |
dc.subject | multiple sclerosis | es_ES |
dc.subject | herding | es_ES |
dc.subject | disease-modifying therapy | es_ES |
dc.subject | neuroeconomics | es_ES |
dc.subject | decision-making | es_ES |
dc.subject | risk aversion | es_ES |
dc.subject.other | CDU::6 - Ciencias aplicadas::61 - Medicina | es_ES |
dc.title | Herding: a new phenomenon affecting medical decision-making in multiple sclerosis care? Lessons learned from DIScUTIR MS | es_ES |
dc.type | info:eu-repo/semantics/article | es_ES |
dc.relation.publisherversion | https://doi.org/10.2147/PPA.S124192 | es_ES |
View/Open:
10-PPA-124192-herding--a-new-phenomenon-affecting-medical-decision-making-_013117 (1).pdf
359,82 kB
Adobe PDF
Share: